CLINICAL_TRIALS
trial_result
· 2020-01-07
Clinical Trial Update: Tongxinluo Capsule for Coronary Microvascular Disease [Phase 4]
Summary
Phase 4 clinical trial update for Tongxinluo Capsule in coronary microvascular disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Qilu Hospital of Shandong University | Conditions: Coronary Microvascular Disease | Phase 4 | Status: UNKNOWN